by jhscmo | Jul 14, 2021 | Media Mentions
Jubilant HollisterStier to Pump $76M into Montreal Facility On July 14 2021, Fierce Pharma reported on the $76Mn expansion of the Jubilant HollisterStier CDMO facility in Montreal, Canada. This investment doubled the facility’s drug production capacity and added new,...
by jhscmo | Jun 15, 2021 | Press Releases
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN® 06.15.2021, Malvern, PA: Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure...
by jhscmo | Jun 3, 2021 | Press Releases
Jubilant HollisterStier Announces $92Mn Expansion for Sterile Injectable Manufacturing Capacity 06.03.2021, Spokane, WA: Jubilant HollisterStier, a wholly owned subsidiary of ultimate parent company Jubilant Pharmova Limited, announces $92M investment to expand...
by jhscmo | Mar 9, 2021 | Media Mentions
Jubilant HollisterStier, Lilly Enter Bamlanivimab Mfg. Pact In March 2021, during the height of the COVID-19 pandemic, Contract Pharma wrote an article detailing Jubilant HollisterStier’s contract with Eli Lilly to manufacture a therapeutic COVID-19 treatment. This...
